Déclaration de participation

Dr. David E. Shaw

Position déclarée

4.032%

Seuil

Franchi à la hausse

Chronologie

Publication

06.03.2025

Transaction

25.02.2025

Répartition des droits

Droits de vote acquis4.032%
Droits de vote cédés0.276%
Sous le seuil0%

Détails de l'annonce

CatégorieActionnaire unique
Place de cotationXSWX

Identifiant de déclaration

ZA01-000000000PV14

Ayant droit économique

Dr. David E. Shaw

Adresse déclarée

Dr David E. Shaw, New York, US

D. E. Shaw Valence International, Inc. has entered into a lock-up agreement with Idorsia Ltd ("Idorsia"), Idorsia Pharmaceuticals Ltd and certain holders of Idorsia convertible bonds 2025 (ISIN CH0426820350) (the "CB2025") and/or Idorsia convertible bonds 2028 (ISIN CH1128004079) (the "CB2028") dated 25 February 2025 (the "Lock-Up Agreement") and is thus a member of the lock-up group disclosed on 3 March 2025. The purchase positions included in this disclosure notification includes only the positions held by D. E. Shaw Valence International, Inc. (alongside other purchase positions held by D. E. Shaw Valence International, Inc. and D. E. Shaw Oculus International, Inc.) that are not locked under the Lock-Up Agreement and, hence, are not covered by the lock-up group disclosure. Under the Lock-Up Agreement and a backstop letter agreement with Idorsia Ltd, Idorsia Pharmaceuticals Ltd and certain holders of CB2025 and/or CB2028, dated 25 February 2025 and to which D. E. Shaw Valence Investments (Cayman) Limited is a party (the "Backstop Letter"; the Backstop Letter together with the Lock-Up Agreement, the "Agreements"), D. E. Shaw Valence International, Inc. and D. E. Shaw Valence Investments (Cayman) Limited collectively hold the rights to receive: - 3'954'369 registered shares of Idorsia (the "Shares") as per different conditions and milestone events as defined in the Agreements up until Q3/2025 as backstop fee, arrangement fee and exchange fee. 1'437'600 Shares to be received under the backstop fee have been finally allocated, but not delivered. The Shares to be received under the arrangement fee and exchange fee have been allocated as of 25 February 2025 but are subject to potential changes before final delivery, pursuant to the Agreements; - 3'634'903 warrants for Shares (with the terms as set forth below, the "Warrant") as per different conditions and milestones events as defined in the Agreements until Q3/2025 as backstop fee, arrangement fee and exchange fee. 1'277'867 Warrants to be received under the backstop fee have been finally allocated, but not delivered. The Warrants to be received under the arrangement fee and exchange fee have been allocated as of 25 February 2025 but are subject to potential changes before final delivery, pursuant to the Agreements.

Ces chiffres sont des agrégats de déclarations publiques. Ils ne constituent pas un conseil en investissement.

Source: SIX Exchange Regulation

insider24.ch

Ne manquez plus aucun signal de marché

Alertes ProPar e-mail et Telegram après publication
Suivi de sociétés illimitéListe de suivi illimitée avec le plan Pro
Récapitulatif du lundiL'essentiel de vos valeurs à l'ouverture